Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug;26(8):e3721.
doi: 10.1002/jgm.3721.

Gene therapy clinical trials worldwide to 2023-an update

Samantha L Ginn  1 , Mawj Mandwie  1 , Ian E Alexander  1   2 , Michael Edelstein  3 , Mohammad R Abedi  4
Affiliations
Review

Gene therapy clinical trials worldwide to 2023-an update

Samantha L Ginn et al. J Gene Med. 2024 Aug.

Abstract

To date, 3,900 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. Our database brings together global information on gene therapy clinical activity from trial databases, official agency sources, published literature, conference presentations and posters kindly provided to us by individual investigators or trial sponsors. This review presents our analysis of clinical trials that, to the best of our knowledge, have been or are being performed worldwide. As of our March 2023 update, we have entries on 3,900 trials undertaken in 46 countries. We have analyzed the geographical distribution of trials, the disease indications (or other reasons) for trials, the proportions to which different vector types are used, and which genes have been transferred. Details of the analyses presented, and our searchable database are on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide website at https://a873679.fmphost.com/fmi/webd/GTCT. We also provide an overview of the progress being made around the world, and discuss key trends since the previous review, namely the unprecedented increase in gene therapy clinical trial activity, including the implementation of genome editing technology with the potential to transform the field moving forward.

Keywords: The Journal of Gene Medicine; clinical trials; database; gene therapy; worldwide.

PubMed Disclaimer

References

REFERENCES

    1. The U.S. Food and Drug Administration. Press Announcement 2017. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss. https://www.fda.gov/news-events/press-announcements/fda-approves-novel-g.... Accessed March 12, 2024.
    1. Sabatino DE, Bushman FD, Chandler RJ, et al. Evaluating the state of the science for adeno‐associated virus integration: an integrated perspective. Mol Ther. 2022;30(8):2646‐2663. doi:10.1016/j.ymthe.2022.06.004
    1. Gallagher T. Meeting summary: ESGCT 2022 AAV safety plenary session. Hum Gene Ther. 2022;33(23–24):1217‐1220. doi:10.1089/hum.2022.29230.tga
    1. Crooke ST. A call to arms against ultra‐rare diseases. Nat Biotechnol. 2021;39(6):671‐677. doi:10.1038/s41587‐021‐00945‐0
    1. University College London. UCL News. 2022. New consortium to ensure access to gene therapies for children with rare diseases. https://www.ucl.ac.uk/news/2022/sep/new-consortium-ensure-access-gene-th.... Accessed March 12, 2024.